EODData

FRA, DAP: Danaher Corporation

04 Sep 2025
LAST:

168.4

CHANGE:
 3.78
OPEN:
170.6
HIGH:
171.2
ASK:
0.0
VOLUME:
189
CHG(%):
2.20
PREV:
172.2
LOW:
166.0
BID:
0.0
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
04 Sep 25170.6171.2166.0168.4189
03 Sep 25174.7175.3172.2172.2286
02 Sep 25175.3176.6172.5172.8368
01 Sep 25175.6176.9175.1175.8175
29 Aug 25175.5176.4175.5176.4108
28 Aug 25176.9177.1175.7176.71.2K
27 Aug 25177.0178.3176.1176.1221
26 Aug 25178.3182.2176.9177.6444
25 Aug 25180.7181.3178.9178.9352
22 Aug 25176.0176.4175.6176.441

COMPANY PROFILE

Name:Danaher Corporation
About:Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment offers bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. Its Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services in the areas of clinical chemistry, immunoassay, hematology, and microbiology for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company has a partnership with AstraZeneca PLC to develop and commercialize diagnostic tools and tests. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and
Sector:Healthcare
Address:2200 Pennsylvania Avenue N.W., Washington, DC, United States, 20037-1701
Website:https://www.danaher.com
ISIN:US2358511028
LEI:S4BKK9OTCEWQ3YHPFM11

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

P/E Ratio:42.73
DivYield:0.01
Div/Share:1.18
Price to Book:2.77
Price to Sales:5.23
EBITDA:7.521B
Shares:716.05M
Market Cap:120.597B

TECHNICAL INDICATORS

MA5:173.12
MA10:175.13
MA20:176.19
MA50:172.83
MA100:172.12
MA200:190.28
RSI14:27.92
WPR14:-100.00
MTM14:-13.04
ROC14:-0.07
ATR:3.24
Week High:177.14
Week Low:166.02
Month High:182.62
Month Low:165.34
Year High:258.23
Year Low:150.37
Volatility:24.18

RECENT SPLITS

Date Ratio
21 May 20042-1

RECENT DIVIDENDS

Date Amount
27 Jun 2025$0.27
28 Mar 2025$0.27
27 Dec 2024$0.23
27 Sep 2024$0.23
28 Jun 2024$0.23
27 Mar 2024$0.23
28 Dec 2023$0.21
11 Oct 2023$0.23
29 Jun 2023$0.23
30 Mar 2023$0.23